The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free DNA analysis as a molecular tool to monitor response to immune checkpoint inhibition in endometrial cancer.
 
Beryl Manning-Geist
No Relationships to Disclose
 
Juber Ahamad A Patel
Research Funding - GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - Systems and Methods for Detecting Cancer via cfDNA Screening (Inst)
 
Antonio Marra
No Relationships to Disclose
 
Arnaud Da Cruz Paula
No Relationships to Disclose
 
Etta J Hanlon
No Relationships to Disclose
 
Nadeem Abu-Rustum
Honoraria - NCCN; Prime Oncology
Research Funding - GRAIL (Inst)
Travel, Accommodations, Expenses - Prime Oncology
 
Ronak H. Shah
Stock and Other Ownership Interests - 10X Genomics; AstraZeneca/MedImmune; Guardant Health; Regeneron; Roche
 
Michael F. Berger
Consulting or Advisory Role - Lilly; PetDx
Research Funding - Grail
Patents, Royalties, Other Intellectual Property - Provisional patent pending for "Systems and Methods for Detecting Cancer via cfDNA Screening"
 
Martee Leigh Hensley
Employment - Sanofi (I)
Stock and Other Ownership Interests - Sanofi (I)
Consulting or Advisory Role - GlaxoSmithKline; Lilly; Tesaro; Thrive, An Exact Sciences Company
Patents, Royalties, Other Intellectual Property - author, Up to Date
 
Dmitriy Zamarin
Stock and Other Ownership Interests - Accurius; Calidi Biotherapeutics; ImmunOs Therapeutics
Consulting or Advisory Role - Agenus; AstraZeneca; Celldex; Crown Bioscience; Genentech/Roche; GlaxoSmithKline; Hookipa Biotech; Memgen; Synlogic; Synthekine; Targovax; Tessa Therapeutics; Xencor
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Plexxikon (Inst)
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
 
Britta Weigelt
Stock and Other Ownership Interests - Repare Therapeutics (I)
Consulting or Advisory Role - Genentech/Roche (I); Goldman Sachs (I); Invicro (I); Lilly (I); PAIGE (I); Repare Therapeutics; Repare Therapeutics (I); Ventana Medical Systems (I); Volition RX (I)
 
Claire Frances Friedman
Honoraria - Aptitude Health; OncLive/MJH Life Sciences
Consulting or Advisory Role - Arch Oncology; Bristol Myers Squibb; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Daiichi Sankyo/UCB Japan (Inst); Genentech (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech; Merck